Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs.

Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare.

Our hosts engage in a fascinating discussion with Sebastian Brunemeier, a true powerhouse in the longevity and regenerative medicine space. Sebastian is a biotech venture capitalist and company builder with a laser focus on extending human health span. As the co-founder and general partner of Healthspan Capital and the CEO and founder of ImmuneAgeBio, Sebastian is at the forefront of immune system rejuvenation research. 

Over the past five years, he has co-founded four longevity biotech companies with a combined equity value exceeding $600 million. Sebastian’s background includes roles as co-founder and chief investment officer at Cambrian Biopharma, co-founder and COO of Samsara Therapeutics, and principal at Apollo Health Ventures, the world’s first and largest aging-focused venture capital fund managing $200 million in assets.

Podcast Highlights:

Social Media:

Other Links/Mentions/Resources:

Show Credits:

This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications. 

Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @KCSAPodcastLabs

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs.

Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare.

Hosts Phil Carlson and Anne Donohoe dive into the world of longevity technology with guest Petr Sramek, a visionary in the field of longevity tech. Petr is the co-founder, chairman, and managing general partner of the Longevitytech.fund, bringing over 33 years of experience as a serial tech entrepreneur to the table. His impressive resume includes being a former entrepreneur-in-residence at Singularity University and co-founder of theLongevityForum.eu.

Currently serving on the boards of several cutting-edge companies in the longevity sector, including Animal Biosciences in the U.S. and Age Curve in the U.K., Petr is dedicated to building the scientific, financial, and business infrastructure needed to accelerate the adoption of technologies that improve our health span.

Podcast Highlights:

Social Media:

Other Links/Mentions/Resources:

Show Credits:

This episode was hosted by Phil Carlson and Anne Donohoe of KCSA Strategic Communications. 

Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs.

Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare.

We sat down with Lou Reese, co-founder and Vice Chairman of Vaxxinity, a purpose-driven biotechnology company pioneering a new class of medicines aimed at disrupting existing treatments for chronic diseases. Founded in 2014 alongside his wife and CEO, Mei Mei Hu, Vaxxinity is at the forefront of developing “next generation” vaccines for chronic conditions such as Alzheimer’s, Parkinson’s, heart disease, and migraine.

Lou Reese also serves on the Executive Committee of United Biomedical, Inc. (UBI), a multinational biopharmaceutical organization focused on developing diagnostics and immunotherapeutics for global health improvement. Lou was a director at ShenLian Biotech, one of the largest animal health companies in China, and co-founded an investment firm with ventures spanning real estate, energy, hospitality, and life sciences.

Podcast Highlights:

Social Media:

Other Links/Mentions/Resources:

Show Credits:

This episode was hosted by Lewis Goldberg of KCSA Strategic Communications. 

Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @KCSAPodcastLabs

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs.

Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare.

We sat down with Dr. Bob Harari, a renowned biomedical scientist, surgeon, and entrepreneur. He is the Founder, Chairman, and CEO of Celularity, a biotechnology company leading the next evolution in cellular medicine. Dr. Hariri pioneered the use of stem cells to treat a range of life-threatening human diseases and continues today to make transformative contributions in the fields of immuno-oncology and cell therapeutics along with tissue engineering and functional regeneration. 

Dr. Hariri is widely acknowledged for his discovery of pluripotent stem cells derived from the human placenta, and as a member of the team that discovered the physiological activities of tumor necrosis factor (TNF). He holds over 150 issued and pending patents for discoveries including placenta-derived stem cells, which Nature recognized as one of the ten most important patent estates in the field. Dr. Hariri was the founder and CEO of Anthrogenesis Corporation, and after its acquisition by Celgene Corporation, served as CEO of Celgene Cellular Therapeutics. Dr. Hariri also co-founded the genomic-based health intelligence company, Human Longevity, Inc.

Podcast Highlights:

Social Media:

Other Links/Mentions/Resources:

Show Credits:

This episode was hosted by Lewis Goldberg of KCSA Strategic Communications. 

Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs.

Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare.

Our hosts sat down with Dr. Moshe Szyf, a pioneering figure in the field of epigenetics with a career spanning over three and a half decades. A founding figure in behavioral and psychiatric epigenetics, Dr. Szyf has authored over 300 influential papers that have significantly contributed to our understanding of how environmental factors and behaviors can influence gene expression without altering the DNA sequence itself. 

Dr. Szyf serves as Chairman, CEO, and Chief Scientific Officer of HKG Epitherapeutics, focusing on developing epigenetic tools for clinical medicine, early disease detection, and personalized healthcare. He also currently holds the prestigious position of James McGill Professor of Pharmacology and Therapeutics at McGill University in Montreal, where he also holds the GlaxoSmithKline Chair in Pharmacology. 

Podcast Highlights:

Social Media:

Other Links/Mentions/Resources:

Show Credits:

This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications. 

Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs.

Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare.

We met with Dr. Nir Barzilai, director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. Dr. Barzilai discovered the first “longevity gene” in humans. His research established that the gene variant that leads to high HDL, or “good cholesterol,” is linked to healthy aging and extreme longevity. 

Treatments for age-related diseases like type 2 diabetes are being developed based on Dr. Barzilai’s work and are currently in clinical trials. In addition to his “longevity gene” research, Dr. Barzilai studies key mechanisms involved in the biology of aging, including how nutrients and genetics influence lifespan. He is also investigating the physical and mental declines associated with aging and how they affect longevity. Dr. Barzilai is professor of medicine (endocrinology) and of genetics, a member of the Diabetes Research Center, and director of the Diabetes Research and Training Center’s Animal Physiology core.

Podcast Highlights:

Social Media:

Other Links/Mentions/Resources:

Show Credits:

This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications. 

Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs.

Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare. 

Our host sat down with Dr. Peter Diamandis, a visionary at the forefront of the longevity revolution. Named by Fortune as one of the “World’s 50 Greatest Leaders,” Diamandis has started over 20 companies in the areas of longevity, space, venture capital, and education. 

Diamandis is the founder & executive chairman of the XPRIZE Foundation, which leads the world in designing & operating large-scale incentive competitions. He is also the co-founder and vice-chairman of Human Longevity Inc., merging advanced genomic sequencing with AI to develop therapies aimed at slowing down or even reversing aging. Additionally, Diamandis co-founded Fountain Life with Tony Robbins, a unique concierge healthcare company dedicated to revolutionizing the healthcare industry. Diamandis is the creator of Abundance360, a year-round program for entrepreneurs, investors, and executives focused on leveraging technology to drive positive change and leave a legacy.

Podcast Highlights:

Guest Social Media:

Other Links/Mentions/Resources:

Show Credits:

This episode was hosted by Lewis Goldberg of KCSA Strategic Communications. 

Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs.

Today our hosts sat down with John Mueller, veteran cannabis entrepreneur and CEO of Greenlight Dispensary. Greenlight is a vertically integrated multi-state operator with more than 30 dispensaries, 3 in-house brands, and more than 750 employees across Missouri, Ohio, West Virginia, Illinois, Nevada, and South Dakota. John is an expert in navigating the complexities of limited license markets and running a debt-free, profitable organization.

John has extensive experience in all areas of cannabis cultivation, manufacturing, dispensing, and retail. Prior to founding Greenlight in 2019, he served as Co-Founder and CEO of Acres Cannabis, successfully building and selling operations to Curaleaf, which included a 19,000 sqft experiential dispensary and over 300,000 sqft of cultivation. Under John’s leadership, Greenlight issued the first known consecutive dividends by a private cannabis MSO, each totaling over seven figures. John also created “The Underground” and “Greenlight Garage” the world’s first-ever cannabis farmers markets where vendors and consumers can directly interact. 

So don’t sit back, lean forward and enjoy!

Social Media:

Other Links/Mentions:

Show Credits:

This episode was hosted by Anne Donohoe and Maria Petsanas of KCSA Strategic Communications. 

Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs.

Today, we sat down with returning guest Adam Smith, Founder and President of Alliance for Sensible Markets to discuss the news that Vice President Kamala Harris will be rolling out her plan for cannabis legalization. Adam is a longtime activist in the industry, primarily working behind the scenes to develop, draft, and lobby for the passage of cannabis bills at both the state and federal levels. Adam conceptualized, co-wrote, and championed Oregon’s landmark 2019 interstate commerce law (on which the 2023 Washington law was also based) and helped write and advocated for California’s 2022 interstate law. His expertise and influence have been instrumental in shaping the legal landscape of cannabis in the United States.

During our conversation, Adam will share his unique insights on Vice President Harris’s upcoming legalization plan, analyzing its potential impact on the industry, the economy, and society at large. We’ll explore the intricate details of the proposal, discuss possible challenges and opportunities, and examine how this federal initiative might interact with existing state laws.

So don’t sit back, lean forward and enjoy!

Social Media:

Other Links/Mentions:

Show Credits:

This episode was hosted by Anne Donohoe and Lewis Goldberg (who still has a bet with Adam!) of KCSA Strategic Communications. 

Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs.

Today, we have a special edition of the Green Rush featuring our newest production, Alternatively Speaking. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare. 

Our hosts sat down with Alternatively Speaking’s first-ever guest, Jamie Justice, Executive Vice President of the Health Domain at XPRIZE Foundation and Adjunct Professor in Internal Medicine Section on Gerontology and Geriatric Medicine, and Sticht Center on Healthy Aging and Alzheimer’s Prevention at Wake Forest University School of Medicine (WFUSM). Jamie is dedicated to Geroscience research that advances the hypothesis that by targeting the basic biology of aging the incidence of multiple age-related diseases can be delayed or prevented.

So don’t sit back, lean forward and enjoy!

Podcast Highlights:

Social Media:

Other Links/Mentions:

Show Credits:

This episode was hosted by Anne Donohoe of KCSA Strategic Communications. 

Special thanks to our Program Director, Shea Gunther and Executive Producer, Maria Petsanas.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels: